Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | JAMA - Journal of the American Medical Association | 2001 | 21.5K |
Functional rafts in cell membranes | Nature | 1997 | 8.1K |
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Circulation | 2005 | 8K |
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Lancet, The | 2012 | 7.6K |
Prediction of coronary heart disease using risk factor categories | Circulation | 1998 | 6.8K |
The steroid and thyroid hormone receptor superfamily | Science | 1988 | 6.7K |
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Lancet, The | 2002 | 6.6K |
Inflammation in atherosclerosis | Nature | 2002 | 6.5K |
Enzymatic Determination of Total Serum Cholesterol | Clinical Chemistry | 1974 | 6.4K |
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | New England Journal of Medicine | 1995 | 6.3K |
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Lancet, The | 1994 | 6.2K |
Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance | Environmental Science & Technology | 2002 | 6.1K |
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | New England Journal of Medicine | 1996 | 6.1K |
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | New England Journal of Medicine | 1998 | 5.2K |
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | New England Journal of Medicine | 1989 | 5.1K |
Lipid rafts and signal transduction | Nature Reviews Molecular Cell Biology | 2000 | 5K |
Extracellular vesicles: exosomes, microvesicles, and friends | Journal of Cell Biology | 2013 | 4.8K |
A receptor-mediated pathway for cholesterol homeostasis | Science | 1986 | 4.7K |
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study | New England Journal of Medicine | 1990 | 4.6K |
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | New England Journal of Medicine | 2000 | 4.6K |
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels | New England Journal of Medicine | 1998 | 4.5K |
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Circulation | 2004 | 4.5K |
The metabolic syndrome | Lancet, The | 2005 | 4.4K |
Membrane lipids: where they are and how they behave | Nature Reviews Molecular Cell Biology | 2008 | 4.3K |
General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Circulation | 2008 | 4.3K |